Robotic EksoSkeleton Therapy for Parkinson's Disease
This study is exploring how well therapy with the Eksobionic Exoskeleton (Ekso) works for people with Parkinson's disease (PD). Ekso is a robotic device designed to help with movement. Researchers want to see how using Ekso affects your walking, balance, and overall quality of life. You would participate in an eight-week program, with assessments before, during, and after. The study aims to enroll up to 24 participants who have been diagnosed with idiopathic (of unknown cause) Parkinson's disease and are willing to do high-intensity gait (walking) training. Success will be measured by how many steps you take per session and how well you progress through the therapy protocol over eight weeks. The current recruitment status is unclear.
- Study design
- This is an interventional study with a planned enrollment of 24 participants. It involves physical therapy using the Ekso robotic device.
- What's involved
- You would have an initial assessment, then attend physical therapy sessions two times per week for eight weeks. Each session lasts 60 minutes, and there will be follow-up assessments after the last session and at 3 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed up at 3 months after the last treatment session.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton
At a glance
Conditions
NCT06225830
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Jefferson Moss-Magee Rehabilitation - Elkins Park
Elkins Park, Pennsylvaniano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Jacqueline Brown, DPT · PRINCIPAL_INVESTIGATOR · Albert Einstein Healthcare Network
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Steps per session & progression through protocol8 weeks
Our goal is to determine the number of steps per session that can be achieved and the rate of progression through various Ekso modes while applying a standardized treatment protocol during Ekso mediated treatment in PwPD. We establish a treatment protocol for use of the Ekso with PwPD, involving two 45-60-minute sessions per week for eight weeks. We hypothesize that under this protocol, participants will achieve \>300 steps per session by the 3rd session and will be able to progress through a series of increasingly challenging training modes by meeting target goals. We will measure the number of sessions required to progress through each step of the training program.